SCHEMBL1647685

SCHEMBL1647685

COCCOC(=O)c1ccc(Cc2c(O)c3ccccc3oc2=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
VKORC1 Q9BQB6 7/20 0.65
NQO1 P15559 6/20 0.60
ALDH1A1 P00352 2/20 0.55
MEN1 O00255 1/20 0.55
ABCB11 O95342 1/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
TSHR P16473 1/20 0.55
MAPK1 P28482 1/20 0.55
CYP2C19 P33261 1/20 0.55
KMT2A Q03164 1/20 0.55
PDE4D Q08499 1/20 0.55
PCSK7 Q16549 1/20 0.55
GPR35 Q9HC97 1/20 0.55
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4957547 0.90 VKORC1 (0.63) VKORC1NQO1ALDH1A1MEN1ABCB11
SCHEMBL1647670 0.88 VKORC1 (0.64) VKORC1NQO1ALDH1A1MEN1ABCB11
SCHEMBL1649128 0.88 ALDH1A1 (0.66) VKORC1NQO1ALDH1A1MEN1ABCB11
SCHEMBL1648184 0.88 VKORC1 (0.72) VKORC1NQO1ALDH1A1MEN1ABCB11
SCHEMBL4399497 0.86 VKORC1 (0.58) VKORC1NQO1ALDH1A1MEN1ABCB11
SCHEMBL1648114 0.85 VKORC1 (0.62) VKORC1NQO1ALDH1A1MEN1ABCB11
SCHEMBL3171054 0.85 VKORC1 (0.61) VKORC1NQO1ALDH1A1MEN1ABCB11
SCHEMBL1647701 0.84 VKORC1 (0.58) VKORC1NQO1ALDH1A1MEN1ABCB11
SCHEMBL13498436 0.83 VKORC1 (0.62) VKORC1NQO1ALDH1A1MEN1ABCB11
SCHEMBL3174074 0.83 TSHR (0.56) VKORC1NQO1ALDH1A1MEN1ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161261-B1 Materials and methods for treating coagulation disorders ARMETHEON INC (US) 2013-08-28 EP disclosed
US-7932405-B2 Halogenated ester derivatives of coumarins for the treatment of coagulation disorders ARYX THERAPEUTICS, INC. (US) 2011-04-26 US disclosed
EP-2161261-A1 Materials and methods for treating coagulation disorders Aryx Therapeutics (US) 2010-03-10 EP disclosed
EP-1735296-B1 MATERIALS AND METHODS FOR TREATING COAGULATION DISORDERS ARYX THERAPEUTICS (US) 2009-12-09 EP disclosed